Bill
HR 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
119th Congress
Introduced by Neal Dunn and 1 co-sponsor
HR 1843 boosts transparency in generic drug applications, ensuring clearer info on equivalence for manufacturers, improving access to reliable, affordable medications for consumers.
Introduced in House